{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:53:45Z","timestamp":1791212025152,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":89,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"CSCO Clinical Oncology Research Foundation","award":["Y-HH202101-0092"],"award-info":[{"award-number":["Y-HH202101-0092"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"DOI":"10.1186\/s13058-026-02343-3","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T19:45:03Z","timestamp":1783539903000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["LMAN2 promotes breast cancer progression and deduces cell sensitivity to doxorubicin through stearoyl-CoA desaturase"],"prefix":"10.1186","volume":"28","author":[{"given":"Changjiao","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengqiang","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chutuo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiling","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4121-7532","authenticated-orcid":false,"given":"Ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"key":"2343_CR1","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1038\/s41591-025-03502-3","volume":"31","author":"J Kim","year":"2025","unstructured":"Kim J, Harper A, McCormack V, Sung H, Houssami N, Morgan E, Mutebi M, Garvey G, Soerjomataram I, Fidler-Benaoudia MM. Global patterns and trends in breast cancer incidence and mortality across 185 countries. Nat Med. 2025;31:1154\u201362. https:\/\/doi.org\/10.1038\/s41591-025-03502-3.","journal-title":"Nat Med"},{"key":"2343_CR2","unstructured":"Ferlay J, Ervik MLM, Lam F, Colombet M, Mery L, Pi\u00f1eros M, Znaor A, Soerjomataram I, Bray F. (2024). Global cancer observatory: cancer tomorrow (version 1.1). Lyon Fr. Int. Agency Res. Cancer. https:\/\/gco.iarc.who.int\/tomorrow (accessed March 18, 2025)."},{"key":"2343_CR3","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1007\/s12032-025-02917-9","volume":"42","author":"K Yang","year":"2025","unstructured":"Yang K, Xie Z, Liu S, Xu R, Mao J, Feng W, Zhao X, Dai Y, Zou Y, Qian R, Qian R. Ursolic acid affects autophagy and apoptosis of breast cancer through PLK1 via AKT\/mTOR signaling pathway. Med Oncol. 2025;42:358. https:\/\/doi.org\/10.1007\/s12032-025-02917-9.","journal-title":"Med Oncol"},{"key":"2343_CR4","doi-asserted-by":"publisher","first-page":"4287","DOI":"10.3390\/cancers13174287","volume":"13","author":"S Lukasiewicz","year":"2021","unstructured":"Lukasiewicz S, Czeczelewski M, Forma A, Baj J, Sitarz R, Stanislawek A. Breast cancer-epidemiology, risk factors, classification, prognostic markers, and current treatment strategies-an updated review. Cancers (Basel). 2021;13:4287. https:\/\/doi.org\/10.3390\/cancers13174287","journal-title":"Cancers (Basel)"},{"key":"2343_CR5","doi-asserted-by":"publisher","first-page":"1669457","DOI":"10.3389\/or.2025.1669457","volume":"19","author":"Y Li","year":"2025","unstructured":"Li Y, Chen S, Zhao Z, Yuan Z, Yuan D. eIF3b-driven autophagy and Wnt\/beta-catenin crosstalk: a novel regulatory axis in adriamycin resistance of breast cancer. Oncol Rev. 2025;19:1669457. https:\/\/doi.org\/10.3389\/or.2025.1669457.","journal-title":"Oncol Rev"},{"key":"2343_CR6","doi-asserted-by":"publisher","first-page":"15886","DOI":"10.1074\/jbc.M211199200","volume":"278","author":"O Nufer","year":"2003","unstructured":"Nufer O, Mitrovic S, Hauri HP. Profile-based data base scanning for animal L-type lectins and characterization of VIPL, a novel VIP36-like endoplasmic reticulum protein. J Biol Chem. 2003;278:15886\u201396. https:\/\/doi.org\/10.1074\/jbc.M211199200.","journal-title":"J Biol Chem"},{"issue":"17","key":"2343_CR7","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1242\/jcs.112.17.2813","volume":"112","author":"J Fullekrug","year":"1999","unstructured":"Fullekrug J, Scheiffele P, Simons K. VIP36 localisation to the early secretory pathway. J Cell Sci. 1999;112(17):2813\u201321. https:\/\/doi.org\/10.1242\/jcs.112.17.2813.","journal-title":"J Cell Sci"},{"key":"2343_CR8","doi-asserted-by":"publisher","first-page":"7623654","DOI":"10.1155\/2022\/7623654","volume":"2022","author":"D Zhang","year":"2022","unstructured":"Zhang D, Ye L, Hu S, Zhu Q, Li C, Zhu C. Comprehensive analysis of the expression and prognostic value of LMAN2 in HER2\u2009+\u2009breast cancer. J Immunol Res. 2022;2022:7623654. https:\/\/doi.org\/10.1155\/2022\/7623654","journal-title":"J Immunol Res"},{"key":"2343_CR9","doi-asserted-by":"publisher","first-page":"e70448","DOI":"10.1002\/cam4.70448","volume":"13","author":"C Feng","year":"2024","unstructured":"Feng C, Li P, Liu P, Wang B, Li J, Liu P. LMAN2 Promotes Breast Cancer Tumorigenesis and Drug Resistance by Interacting With MAPK9 via Activation of the MAPK Pathway. Cancer Med. 2024;13:e70448. https:\/\/doi.org\/10.1002\/cam4.70448.","journal-title":"Cancer Med"},{"key":"2343_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1139\/bcb-2024-0166","volume":"103","author":"S Xiao","year":"2025","unstructured":"Xiao S, Yu T, Yang F, Yuan H, Ni J. LMAN2 interacts with HEATR3 to expedite HER2-positive breast cancer advancement and inflammation and Akt\/ERK\/NF-kappaB signaling. Biochem Cell Biol. 2025;103:1\u201311. https:\/\/doi.org\/10.1139\/bcb-2024-0166.","journal-title":"Biochem Cell Biol"},{"key":"2343_CR11","doi-asserted-by":"publisher","first-page":"eadh1891","DOI":"10.1126\/sciadv.adh1891","volume":"9","author":"J Cui","year":"2023","unstructured":"Cui J, Christin JR, Reisz JA, Cendali FI, Sanawar R, De Miranda C, D\u2019Alessandro M, A., and, Guo W. Targeting ABCA12-controlled ceramide homeostasis inhibits breast cancer stem cell function and chemoresistance. Sci Adv. 2023;9:eadh1891. https:\/\/doi.org\/10.1126\/sciadv.adh1891.","journal-title":"Sci Adv"},{"key":"2343_CR12","doi-asserted-by":"publisher","first-page":"e2200321","DOI":"10.1002\/pmic.202200321","volume":"23","author":"HW Chu","year":"2023","unstructured":"Chu HW, Chang KP, Yen WC, Liu HP, Chan XY, Liu CR, Hung CM, Wu CC. Identification of salivary autoantibodies as biomarkers of oral cancer with immunoglobulin A enrichment combined with affinity mass spectrometry. Proteomics. 2023;23(e2200321). https:\/\/doi.org\/10.1002\/pmic.202200321","journal-title":"Proteomics"},{"key":"2343_CR13","doi-asserted-by":"publisher","first-page":"5103","DOI":"10.1038\/s41467-021-25354-4","volume":"12","author":"W Liu","year":"2021","unstructured":"Liu W, Chakraborty B, Safi R, Kazmin D, Chang CY, McDonnell DP. Dysregulated cholesterol homeostasis results in resistance to ferroptosis increasing tumorigenicity and metastasis in cancer. Nat Commun. 2021;12:5103. https:\/\/doi.org\/10.1038\/s41467-021-25354-4.","journal-title":"Nat Commun"},{"key":"2343_CR14","doi-asserted-by":"publisher","DOI":"10.2174\/0109298673396050250729132235","author":"ID Antipenko","year":"2025","unstructured":"Antipenko ID, Makarova JA, Shkurnikov MY, Tonevitsky AG. The Impact of IGFBP6 Knockdown on Cholesterol Metabolism in Breast Cancer Cells. Curr Med Chem. 2025. https:\/\/doi.org\/10.2174\/0109298673396050250729132235.","journal-title":"Curr Med Chem"},{"key":"2343_CR15","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/nature04399","volume":"438","author":"FR Maxfield","year":"2005","unstructured":"Maxfield FR, Tabas I. Role of cholesterol and lipid organization in disease. Nature. 2005;438:612\u201321. https:\/\/doi.org\/10.1038\/nature04399.","journal-title":"Nature"},{"key":"2343_CR16","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.trecan.2023.03.003","volume":"9","author":"U Sen","year":"2023","unstructured":"Sen U, Coleman C, Sen T. Stearoyl coenzyme A desaturase-1: multitasker in cancer, metabolism, and ferroptosis. Trends Cancer. 2023;9:480\u20139. https:\/\/doi.org\/10.1016\/j.trecan.2023.03.003.","journal-title":"Trends Cancer"},{"key":"2343_CR17","doi-asserted-by":"publisher","first-page":"952371","DOI":"10.3389\/fonc.2022.952371","volume":"12","author":"Q Zhao","year":"2022","unstructured":"Zhao Q, Lin X, Wang G. Targeting SREBP-1-Mediated Lipogenesis as Potential Strategies for Cancer. Front Oncol. 2022;12:952371. https:\/\/doi.org\/10.3389\/fonc.2022.952371.","journal-title":"Front Oncol"},{"key":"2343_CR18","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1038\/s44321-024-00090-6","volume":"16","author":"N Lorito","year":"2024","unstructured":"Lorito N, Subbiani A, Smiriglia A, Bacci M, Bonechi F, Tronci L, Romano E, Corrado A, Longo DL, Iozzo M, et al. FADS1\/2 control lipid metabolism and ferroptosis susceptibility in triple-negative breast cancer. EMBO Mol Med. 2024;16:1533\u201359. https:\/\/doi.org\/10.1038\/s44321-024-00090-6.","journal-title":"EMBO Mol Med"},{"key":"2343_CR19","doi-asserted-by":"publisher","first-page":"13116","DOI":"10.1038\/s41598-024-64043-2","volume":"14","author":"T Ikeda","year":"2024","unstructured":"Ikeda T, Katoh Y, Hino H, Seta D, Ogawa T, Iwata T, Nishio H, Sugawara M, Hirai S. FADS2 confers SCD1 inhibition resistance to cancer cells by modulating the ER stress response. Sci Rep. 2024;14:13116. https:\/\/doi.org\/10.1038\/s41598-024-64043-2.","journal-title":"Sci Rep"},{"key":"2343_CR20","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1186\/s12885-017-3936-7","volume":"17","author":"LH Huang","year":"2017","unstructured":"Huang LH, Chung HY, Su HM. Docosahexaenoic acid reduces sterol regulatory element binding protein-1 and fatty acid synthase expression and inhibits cell proliferation by inhibiting pAkt signaling in a human breast cancer MCF-7 cell line. BMC Cancer. 2017;17:890. https:\/\/doi.org\/10.1186\/s12885-017-3936-7","journal-title":"BMC Cancer"},{"key":"2343_CR21","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1080\/14728222.2017.1381087","volume":"21","author":"JA Menendez","year":"2017","unstructured":"Menendez JA, Lupu R. Fatty acid synthase (FASN) as a therapeutic target in breast cancer. Expert Opin Ther Targets. 2017;21:1001\u201316. https:\/\/doi.org\/10.1080\/14728222.2017.1381087.","journal-title":"Expert Opin Ther Targets"},{"key":"2343_CR22","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.bbrc.2015.08.101","volume":"465","author":"A Shikama","year":"2015","unstructured":"Shikama A, Shinozaki H, Takeuchi Y, Matsuzaka T, Aita Y, Murayama T, Sawada Y, Piao X, Toya N, Oya Y, et al. Identification of human ELOVL5 enhancer regions controlled by SREBP. Biochem Biophys Res Commun. 2015;465:857\u201363. https:\/\/doi.org\/10.1016\/j.bbrc.2015.08.101.","journal-title":"Biochem Biophys Res Commun"},{"key":"2343_CR23","doi-asserted-by":"publisher","first-page":"4170","DOI":"10.3390\/cancers13164170","volume":"13","author":"S Tomida","year":"2021","unstructured":"Tomida S, Goodenowe DB, Koyama T, Ozaki E, Kuriyama N, Morita M, Yamazaki Y, Sakaguchi K, Uehara R, Taguchi T. Plasmalogen deficiency and overactive fatty acid elongation biomarkers in serum of breast cancer patients pre- and post-surgery-new insights on diagnosis, risk assessment, and disease mechanisms. Cancers (Basel). 2021;13:4170. https:\/\/doi.org\/10.3390\/cancers13164170","journal-title":"Cancers (Basel)"},{"key":"2343_CR24","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/s41419-022-05209-6","volume":"13","author":"TL Kieu","year":"2022","unstructured":"Kieu TL, Pierre L, Derangere V, Perrey S, Truntzer C, Jalil A, Causse S, Groetz E, Dumont A, Guyard L, et al. Downregulation of Elovl5 promotes breast cancer metastasis through a lipid-droplet accumulation-mediated induction of TGF-beta receptors. Cell Death Dis. 2022;13:758. https:\/\/doi.org\/10.1038\/s41419-022-05209-6.","journal-title":"Cell Death Dis"},{"key":"2343_CR25","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.canlet.2017.03.025","volume":"397","author":"J O\u2019Malley","year":"2017","unstructured":"O\u2019Malley J, Kumar R, Kuzmin AN, Pliss A, Yadav N, Balachandar S, Wang J, Attwood K, Prasad PN, Chandra D. Lipid quantification by Raman microspectroscopy as a potential biomarker in prostate cancer. Cancer Lett. 2017;397:52\u201360. https:\/\/doi.org\/10.1016\/j.canlet.2017.03.025.","journal-title":"Cancer Lett"},{"key":"2343_CR26","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s13402-022-00767-5","volume":"46","author":"YC Huang","year":"2023","unstructured":"Huang YC, Hou MF, Tsai YM, Pan YC, Tsai PH, Lin YS, Chang CY, Tsai EM, Hsu YL. Involvement of ACACA (acetyl-CoA carboxylase alpha) in the lung pre-metastatic niche formation in breast cancer by senescence phenotypic conversion in fibroblasts. Cell Oncol (Dordr). 2023;46:643\u201360. https:\/\/doi.org\/10.1007\/s13402-022-00767-5.","journal-title":"Cell Oncol (Dordr)"},{"key":"2343_CR27","doi-asserted-by":"publisher","first-page":"9892","DOI":"10.3168\/jds.2023-23602","volume":"106","author":"S Zhou","year":"2023","unstructured":"Zhou S, Chen M, Meng M, Ma N, Xie W, Shen X, Li Z, Chang G. Subclinical ketosis leads to lipid metabolism disorder by downregulating the expression of acetyl-coenzyme A acetyltransferase 2 in dairy cows. J Dairy Sci. 2023;106:9892\u2013909. https:\/\/doi.org\/10.3168\/jds.2023-23602.","journal-title":"J Dairy Sci"},{"key":"2343_CR28","doi-asserted-by":"publisher","first-page":"5896","DOI":"10.3390\/cancers14235896","volume":"14","author":"Y Yang","year":"2022","unstructured":"Yang Y, Zhu T, Wang X, Xiong F, Hu Z, Qiao X, Yuan X, Wang D. ACSL3 and ACSL4, Distinct roles in ferroptosis and cancers. Cancers (Basel). 2022;14:5896. https:\/\/doi.org\/10.3390\/cancers14235896","journal-title":"Cancers (Basel)"},{"key":"2343_CR29","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1038\/s44321-024-00142-x","volume":"16","author":"T Ackermann","year":"2024","unstructured":"Ackermann T, Shokry E, Deshmukh R, Anand J, Galbraith LCA, Mitchell L, Rodriguez-Blanco G, Villar VH, Sterken BA, Nixon C, et al. Breast cancer secretes anti-ferroptotic MUFAs and depends on selenoprotein synthesis for metastasis. EMBO Mol Med. 2024;16:2749\u201374. https:\/\/doi.org\/10.1038\/s44321-024-00142-x.","journal-title":"EMBO Mol Med"},{"key":"2343_CR30","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/s42003-025-07977-1","volume":"8","author":"A Sammarco","year":"2025","unstructured":"Sammarco A, Guerra G, Eyme KM, Kennewick K, Qiao Y, Hokayem E, Williams J, Su KJ, Cakici B, Mnatsakanyan C, H., et al. Targeting SCD triggers lipotoxicity of cancer cells and enhances anti-tumor immunity in breast cancer brain metastasis mouse models. Commun Biol. 2025;8:562. https:\/\/doi.org\/10.1038\/s42003-025-07977-1.","journal-title":"Commun Biol"},{"key":"2343_CR31","doi-asserted-by":"publisher","first-page":"875318","DOI":"10.3389\/fcell.2022.875318","volume":"10","author":"R Yang","year":"2022","unstructured":"Yang R, Yi M, Xiang B. Novel Insights on Lipid Metabolism Alterations in Drug Resistance in Cancer. Front Cell Dev Biol. 2022;10:875318. https:\/\/doi.org\/10.3389\/fcell.2022.875318.","journal-title":"Front Cell Dev Biol"},{"key":"2343_CR32","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12943-025-02258-1","volume":"24","author":"M Wan","year":"2025","unstructured":"Wan M, Pan S, Shan B, Diao H, Jin H, Wang Z, Wang W, Han S, Liu W, He J, et al. Lipid metabolic reprograming: the unsung hero in breast cancer progression and tumor microenvironment. Mol Cancer. 2025;24:61. https:\/\/doi.org\/10.1186\/s12943-025-02258-1.","journal-title":"Mol Cancer"},{"key":"2343_CR33","doi-asserted-by":"publisher","first-page":"114959","DOI":"10.5306\/wjco.v17.i2.114959","volume":"17","author":"C Zhang","year":"2026","unstructured":"Zhang C, Wang H, Yang YH. Lipid metabolism in pancreatic cancer treatment. World J Clin Oncol. 2026;17:114959. https:\/\/doi.org\/10.5306\/wjco.v17.i2.114959.","journal-title":"World J Clin Oncol"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13058-026-02343-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-026-02343-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-026-02343-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:02:47Z","timestamp":1791208967000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13058-026-02343-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2343"],"URL":"https:\/\/doi.org\/10.1186\/s13058-026-02343-3","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]},"assertion":[{"value":"13 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"No human subjects were involved; all animal experiments were approved by the Animal Ethics Committee of First Affiliated Hospital of The Fourth Military Medical University.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"168"}}